MAPT and Alzheimer disease: Levels of key proteins, including BACE-1, γ-secretase, soluble Aβ42, soluble sAPPβ and sAPPα, and p-tau-181 and p-tau-S396, were significantly higher in ADEs compared to NDEs in both patients with AD and healthy individuals.